Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Quinoxalinol(9CI) is a heterocyclic chemical compound with the molecular formula C8H6N2O. It features a quinoxaline ring and a hydroxyl group attached to the carbon atoms, making it a versatile compound with potential applications in various fields.

144499-26-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 144499-26-3 Structure
  • Basic information

    1. Product Name: 2-Quinoxalinol(9CI)
    2. Synonyms: 2-Quinoxalinol(9CI)
    3. CAS NO:144499-26-3
    4. Molecular Formula: C8H6N2O
    5. Molecular Weight: 146.15
    6. EINECS: N/A
    7. Product Categories: QUINOXALINE
    8. Mol File: 144499-26-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.347
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-Quinoxalinol(9CI)(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-Quinoxalinol(9CI)(144499-26-3)
    11. EPA Substance Registry System: 2-Quinoxalinol(9CI)(144499-26-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 144499-26-3(Hazardous Substances Data)

144499-26-3 Usage

Uses

Used in Pharmaceutical Industry:
2-Quinoxalinol(9CI) is used as an intermediate in the synthesis of pharmaceuticals for its potential biological activities, such as antifungal and antibacterial properties. Its unique structure allows it to be a promising candidate for the development of new drugs.
Used in Agrochemical Industry:
2-Quinoxalinol(9CI) is used as a building block in the production of agrochemicals, contributing to the development of effective pesticides and other agricultural chemicals that can protect crops and enhance yield.
Used in Organic Synthesis:
2-Quinoxalinol(9CI) is utilized as a versatile compound in organic synthesis, enabling the creation of a wide range of chemical products with various applications, from dyes to polymers.
Used in Research and Development:
2-Quinoxalinol(9CI) is employed as a subject of interest in research and development, where its properties and potential uses are continuously explored and studied to expand its applications in different industries.

Check Digit Verification of cas no

The CAS Registry Mumber 144499-26-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,4,4,9 and 9 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 144499-26:
(8*1)+(7*4)+(6*4)+(5*4)+(4*9)+(3*9)+(2*2)+(1*6)=153
153 % 10 = 3
So 144499-26-3 is a valid CAS Registry Number.

144499-26-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1H-quinoxalin-2-one

1.2 Other means of identification

Product number -
Other names 2-Hydroxyquinoxaline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:144499-26-3 SDS

144499-26-3Relevant articles and documents

One-pot multicomponent synthesis of novel 2-(piperazin-1-yl) quinoxaline and benzimidazole derivatives, using a novel sulfamic acid functionalized Fe3O4 MNPs as highly effective nanocatalyst

Esam, Zohreh,Akhavan, Malihe,Bekhradnia, Ahmadreza

, (2020/10/27)

The immobilization of sulfonic acid on the surface of Fe3O4 magnetic nanoparticles (MNPs) as a novel acid nanocatalyst has been successfully reported. The morphological features, thermal stability, magnetic properties, and other physicochemical properties of the prepared superparamagnetic core–shell (Fe3O4@PFBA–Metformin@SO3H) were thoroughly characterized using Fourier transform infrared (FTIR), X-ray diffraction (XRD), energy-dispersive X-ray spectroscopy (EDS), field-emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), thermogravimetric analysis–differential thermal analysis (TGA-DTA), atomic force microscopy (AFM), dynamic light scattering (DLS), Brunauer–Emmett–Teller (BET), and vibrating sample magnetometer (VSM) techniques. It was applied as an efficient and reusable catalyst for the synthesis of 2-(piperazin-1-yl) quinoxaline and benzimidazole derivatives via a one-pot multiple-component cascade reaction under green conditions. The results displayed the excellent catalytic activity of Fe3O4@PFBA–metformin@SO3H as an organic–inorganic hybrid nanocatalyst in condensation and multicomponent Mannich-type reactions. The easy separation, simple workup, excellent stability, and reusability of the nanocatalyst and quantitative yields of products and short reaction time are some outstanding advantages of this protocol.

Decarboxylative Hydroxylation of Benzoic Acids

Ritter, Tobias,Su, Wanqi,Xu, Peng

, p. 24012 - 24017 (2021/10/06)

Herein, we report the first decarboxylative hydroxylation to synthesize phenols from benzoic acids at 35 °C via photoinduced ligand-to-metal charge transfer (LMCT)-enabled radical decarboxylative carbometalation. The aromatic decarboxylative hydroxylation is synthetically promising due to its mild conditions, broad substrate scope, and late-stage applications.

Multi-gram preparation of 7-nitroquinoxalin-2-amine

Do Amaral, Daniel N.,De Sá Alves, Fernando R.,Barreiro, Eliezer J.,Laufer, Stefan A.,Lima, Lídia M.

, p. 1874 - 1878 (2017/09/02)

Methodologies to obtain quinoxaline compounds regioselectively are rarely reported in literature, thus regioselective and multi-gram methodologies to obtain these derivatives are desirable to explore the entire potential of these scaffolds for academic and/or commercial application. A facile and multi-gram methodology is described to obtain compound 7-nitroquinoxalin-2-amine using o-phenylenediamine, a cheap and readily available reactant, as starting material in a five-step procedure in good yields and high purity without further purification such as crystallization or column chromatography.

Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof

-

Page/Page column 355; 356, (2016/04/26)

The present invention provides for a method for treating a disease condition associated with PI3-kinase α and/or mTOR in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase α and/or mTOR in a subject. In yet another aspect, a method of inhibiting phosphorylation of both Akt (S473) and Akt (T308) in a cell is set forth.

Dibenzothiophene Catabolism Proceeds via a Flavin-N5-oxide Intermediate

Adak, Sanjoy,Begley, Tadhg P.

supporting information, p. 6424 - 6426 (2016/06/09)

The dibenzothiophene catabolic pathway converts dibenzothiophene to 2-hydroxybiphenyl and sulfite. The third step of the pathway, involving the conversion of dibenzothiophene sulfone to 2-(2-hydroxyphenyl)-benzenesulfinic acid, is catalyzed by a unique flavoenzyme DszA. Mechanistic studies on this reaction suggest that the C2 hydroperoxide of dibenzothiophene sulfone reacts with flavin to form a flavin-N5-oxide. The intermediacy of the flavin-N5-oxide was confirmed by LC-MS analysis, a co-elution experiment with chemically synthesized FMN-N5-oxide and 18O2 labeling studies.

COMBINATION OF KINASE INHIBITORS AND USES THEREOF

-

Page/Page column 73, (2015/02/19)

The present invention provides for a method for treating a disease condition associated with PI3-kinase a and/or a receptor tyrosine kinase (RTK) in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase α and/or an RTK in a subject. In yet another aspect, a method of inhibiting phosphorylation of Akt (S473) in a cell is set forth.

COMBINATION OF KINASE INHIBITORS AND USES THEREOF

-

Paragraph 00641, (2014/10/04)

The present invention provides for a method for treating a disease condition associated with PI3-kinase a and/or mTOR in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase a and/or mTOR in a subject. In yet another aspect, a method of inhibiting phosphorylation of both Akt (S473) and Akt (T308) in a cell is set forth. The present invention also provides a pharmaceutical kit effective for treating a disease condition associated with PI3 -kinase α and/or mTOR in a subject.

Rapidly formed quinalphos complexes with transition metal ions characterized by electrospray ionization mass spectrometry

Keller, Bernd O.,Esbata, Abdelhamid A.,Buncel, Erwin,Van Loon, Gary W.

, p. 1319 - 1328 (2013/07/28)

RATIONALE Electrospray ionization tandem mass spectrometry (ESI-MS/MS) offers the unique opportunity to characterize complexes of the organophosphorus pesticide (OP) quinalphos (PA-Q) with transition metal ions immediately formed after contact. This study complements research looking at longer term kinetics of quinalphos hydrolysis in the presence of transition metal ions and gives insights into the structural features of the initial complex formation in solution. (Hydrolysis reaction: PA-Q + H2O → PA-OH + HQ, where PA-OH is the diethyl phosphate product and HQ is hydroxyquinoxaline.) METHODS Low micromolar PA-Q solutions with an approximately 3-fold molar excess of transition metal ions were immediately analyzed after mixing. Fragmentation of the transition metal ion complexes with PA-Q was accomplished in two different ways: first, in-source fragmentation by elevating the declustering potential and second, low-energy collision-induced dissociation (CID). RESULTS For Ag +, the [PA-Q - Ag+] and respective Ag+- containing degradation product ions are readily observed. For Cu2+, we observed the [PA-Q + Cu2+ + NO3-] complex ion with weak intensity and strong signals from both the [2PA-Q + Cu +] and the [PA-Q + Cu+] ions, the latter two attributable to charge-state reduction in the gas phase from Cu(II) to Cu(I), indicating that PA-Q fulfills specific structural requirements of the formed complex for charge-state reduction during transition from solution to the gas phase. For Hg2+, the [PA-Q + Hg2+ + (PA-OH - H)-] ion was the largest observed species containing one Hg2+ ion. No 1:1 species ([PA-Q] or other degradation products:Hg2+) was observable. CONCLUSIONS ESI-MS/MS of complexes formed from PA-Q and transition metal ions is a formidable technique to probe initial formation of these complexes in solution. Previous work from other groups established structural requirements that enable charge-state reduction from Cu(II) to Cu(I) in ligand complexes during transition into the gas phase, and these rules allow us to propose structural features of PA-Q complexes with copper ions in solution. Copyright 2013 John Wiley & Sons, Ltd. Copyright

Design, synthesis, and preliminary in vitro and in vivo pharmacological evaluation of 4-{4-[2-(4-(2-substitutedquinoxalin-3-yl)piperazin-1-yl)ethyl] phenyl}thiazoles as atypical antipsychotic agents

Chandra Sekhar, Kondapalli Venkata Gowri,Rao, Vajja Sambasiva,Deuther-Conrad, Winnie,Sridhar, Divya,Nagesh, Hunsur Nagendra,Kumar, Vellas Sreedhar,Brust, Peter,Kumar, Muthyala Murali Krishna

, p. 1660 - 1673 (2013/07/26)

A series of 4-{4-[2-(4-(2-substitutedquinoxalin-3-yl)piperazin-1-yl)ethyl] phenyl} thiazoles were synthesized in an effort to prepare novel atypical antipsychotic agents. The compounds were designed, synthesized, and characterized by spectral data (IR, 1H NMR, and MS) and the purity was ascertained by microanalysis. The D2 and 5-HT2A affinity of the synthesized compounds was screened in vitro by radioligand displacement assays on membrane homogenates isolated from rat striatum and rat cortex, respectively. Furthermore, all the synthesized final compounds (10a-g; 11a-g; 12a-g) were screened for their in vivo pharmacological activity in Swiss albino mice. D2 antagonism studies were performed using climbing mouse assay model and 5-HT2A antagonism studies were performed using quipazine-induced head twitches in mice. It was observed that none of the new chemical entities exhibited catalepsy and 12d, 11f, and 10a were found to be the most active compounds with 5-HT2A/D2 ratio of 1.23077, 1.14286, and 1.12857, respectively, while the standard drug risperidone exhibited 5-HT2A/D2 ratio of 1.0989. Among the twenty one new chemical entities, three compounds (12d, 11f, and 10a) were found to exhibit better atypical antipsychotic activity as they were found to have higher Meltzer index than the standard drug risperidone.

Kinetics of the reaction of 2-chloro-quinoxaline with hydroxide ion in ACN-H2O and DMSO-H2O binary solvent mixtures

Fathalla, Magda F.

experimental part, p. 1258 - 1270 (2012/06/18)

The kinetics of alkaline hydrolysis of 2-chloroquinoxaline (QCl) with hydroxide ion was investigated spectrophotometrically at different percentages of aqueous-organic solvent mixtures with acetonitrile (10-60% v/v) and with dimethylesulphoxide (10-80%) over the temperature range from 25 to 45 °C. The reaction was performed under pseudo first order conditions with respect to 2-chloroquinoxaline (QCl). An increase in the percentage of organic solvent (v/v) has different effects on the reaction rate constants, presumably due to hydrogen bond donor and acceptor differences of the media and other solvatochromic parameters. The data were discussed in terms of the Kamelt-Taft parameter and ET(30). A nonlinear relation between the logarithm of the rate constant and reciprocal of the dielectric constant suggests the presence of selective solvation by the polar water molecules. Activation parameters δH#, δS# and δG# were determined and discussed. Springer Science+Business Media, LLC 2011.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 144499-26-3